The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib study of PI3Kα inhibitor risovalisib mesylate in combination with fulvestrant in patients with PIK3CA-mutated, HR+/HER2- advanced breast cancer.
 
Jiong Wu
No Relationships to Disclose
 
Jian Zhang
No Relationships to Disclose
 
Man Li
No Relationships to Disclose
 
Li Cai
No Relationships to Disclose
 
Tao Sun
No Relationships to Disclose
 
Quchang Ouyang
No Relationships to Disclose
 
Yanchun Meng
No Relationships to Disclose
 
Yehui Shi
No Relationships to Disclose
 
Chuan Wang
No Relationships to Disclose
 
Qiang Liu
No Relationships to Disclose
 
Yongkui Lu
No Relationships to Disclose
 
Yongmei Yin
No Relationships to Disclose
 
Qianjun Chen
No Relationships to Disclose
 
Lilin Chen
No Relationships to Disclose
 
Haitao Wang
No Relationships to Disclose
 
Jiuwei Cui
No Relationships to Disclose
 
Ning Liao
No Relationships to Disclose
 
Shubin Wang
No Relationships to Disclose
 
Yi Tu
No Relationships to Disclose
 
Min Yan
No Relationships to Disclose